Clinical Trials Directory

Trials / Unknown

UnknownNCT00545961

Middle Meatal Bacteriology During Acute Respiratory Infection in Children

Clinical Relevance of Middle Meatal Bacteriology During Acute Respiratory Infection in Children - Randomised, Double-Blinded Clinical Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Oulu University Hospital · Academic / Other
Sex
All
Age
6 Years – 13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out whether the children with respiratory infection and the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus benefit from antimicrobial treatment.

Detailed description

Acute sinusitis is one of the most common disease in children requiring antimicrobial treatment. The diagnosis and treatment outcomes of acute sinusitis are contradictory, and better diagnostic criteria are needed. In adults with acute maxillary sinusitis, bacterial culture results obtained from the nasal middle meatus are comparable to those obtained from sinus puncture and aspiration. In children, the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection predicts longer duration of signs and symptoms of common cold. In this randomized placebo-controlled study, the effect of the antimicrobial treatment (amoxicillin-clavulanate) is examined in children with pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection. The duration of the symptoms and speed of recovery is recognized by daily symptom-diary, the results are compared between the treatment groups.

Conditions

Interventions

TypeNameDescription
DRUGplacebomixture, 0.28125 ml/kg twice a day for 7 days
DRUGamoxicillin clavulanate acidmixture 0.28125 ml / kg twice a day for 7 days

Timeline

Start date
2007-11-01
Completion
2009-12-01
First posted
2007-10-18
Last updated
2007-10-19

Locations

3 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT00545961. Inclusion in this directory is not an endorsement.